No profile data available.
Jrsis Health Care Corporation (JRSS) is a manufacturing and production company in the highway transit services industry, based in Yongzhou, China, with about 36 full-time employees.
It reported revenue of $1.32 million for fiscal year 2024, down 61.7% from fiscal year 2023, and net income of -$509,790. In Q1 2025 (the quarter ended March 31, 2025) revenue was $137,931, down 72.4% from a year before. Its largest business segment, Service, brought in 37% of segment revenue in fiscal year 2020. Its market capitalization was $1.30 million as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 8, 2026.
JRSIS Health Care Corporation develops and produces medical technology and equipment in the People's Republic of China. The company develops and markets a multi-faceted smart environment for the retail distribution of pharmaceutical products by pharmacies, hospitals, and online distributors.
Jrsis Health Care reported $1.32 million in revenue for fiscal year 2024, down 61.7% from $3.46 million in fiscal year 2023. In Q1 2025 revenue was $137,931.
Service, with $26.31 million or 37% of segment revenue in fiscal year 2020. Next: MedicalConsultingMember (18%) and MedicalTreatmentMember (17%).
$1.30 million as of October 8, 2026.
Listed companies of a similar size in the same industry (highway transit services) include Shengfeng Development Limited (SFWL), NextNRG Inc. (NXXT), Toppoint Holdings Inc. (TOPP), MC Endeavors, Inc. (MSMY).